These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 9726240)

  • 1. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.
    Ishizuka T; Itaya S; Wada H; Ishizawa M; Kimura M; Kajita K; Kanoh Y; Miura A; Muto N; Yasuda K
    Diabetes; 1998 Sep; 47(9):1494-500. PubMed ID: 9726240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of PI 3-kinase products in platelets by thrombin, but not collagen, is dependent on synergistic autocrine stimulation, particularly through secreted ADP.
    Selheim F; Idsøe R; Fukami MH; Holmsen H; Vassbotn FS
    Biochem Biophys Res Commun; 1999 Oct; 263(3):780-5. PubMed ID: 10512757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine kinases and phosphoinositide metabolism in thrombin-stimulated human platelets.
    Guinebault C; Payrastre B; Sultan C; Mauco G; Breton M; Levy-Toledano S; Plantavid M; Chap H
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):851-6. PubMed ID: 8391259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid.
    Packham MA; Livne AA; Ruben DH; Rand ML
    Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):849-56. PubMed ID: 8384448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of phospholipase D in human platelets by collagen and thrombin and its relationship to platelet aggregation.
    Chiang TM
    Biochim Biophys Acta; 1994 Oct; 1224(1):147-55. PubMed ID: 7948037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C.
    Durante W; Kroll MH; Vanhoutte PM; Schafer AI
    Blood; 1992 Jan; 79(1):110-6. PubMed ID: 1309423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inhibitory effects of troglitazone and its metabolites on drug oxidation activities of human cytochrome P450 enzymes: comparison with pioglitazone and rosiglitazone.
    Yamazaki H; Suzuki M; Tane K; Shimada N; Nakajima M; Yokoi T
    Xenobiotica; 2000 Jan; 30(1):61-70. PubMed ID: 10659951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troglitazone induces apoptosis via the p53 and Gadd45 pathway in vascular smooth muscle cells.
    Okura T; Nakamura M; Takata Y; Watanabe S; Kitami Y; Hiwada K
    Eur J Pharmacol; 2000 Nov; 407(3):227-35. PubMed ID: 11068018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocation-independent activation of protein kinase C by platelet-activating factor, thrombin and prostacyclin. Lack of correlation with polyphosphoinositide hydrolysis in rabbit platelets.
    Salari H; Duronio V; Howard S; Demos M; Pelech SL
    Biochem J; 1990 May; 267(3):689-96. PubMed ID: 2160234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of the diacylglycerol kinase inhibitor R59022 on thrombin versus collagen-induced human platelet secretion.
    Joseph S; Krishnamurthi S; Kakkar VV
    Biochim Biophys Acta; 1988 Apr; 969(1):9-17. PubMed ID: 2832002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troglitazone has a reducing effect on thromboxane production.
    Hishinuma T; Yamazaki T; Mizugaki M
    Prostaglandins Other Lipid Mediat; 2000 Jul; 62(2):135-43. PubMed ID: 10938407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol turnover in platelet activation; calcium mobilization and protein phosphorylation.
    Kaibuchi K; Sano K; Hoshijima M; Takai Y; Nishizuka Y
    Cell Calcium; 1982 Oct; 3(4-5):323-35. PubMed ID: 6218878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycemic subjects at risk for the development of type 2 diabetes.
    Meyer MM; Levin K; Grimmsmann T; Perwitz N; Eirich A; Beck-Nielsen H; Klein HH
    Diabetes; 2002 Sep; 51(9):2691-7. PubMed ID: 12196460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation, and secretion.
    White JG; Rao GH; Gerrard JM
    Am J Pathol; 1977 Aug; 88(2):387-402. PubMed ID: 879276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of troglitazone and pioglitazone on cytokine-mediated endothelial cell proliferation in vitro.
    Gralinski MR; Rowse PE; Breider MA
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):909-13. PubMed ID: 9641476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets.
    Puri RN; Zhou F; Hu CJ; Colman RF; Colman RW
    Blood; 1991 Feb; 77(3):500-7. PubMed ID: 1846761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts.
    Kellerer M; Kroder G; Tippmer S; Berti L; Kiehn R; Mosthaf L; Häring H
    Diabetes; 1994 Mar; 43(3):447-53. PubMed ID: 7508875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation.
    Werner MH; Senzel L; Bielawska A; Khan W; Hannun YA
    Mol Pharmacol; 1991 Apr; 39(4):547-56. PubMed ID: 2017154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin-induced human platelet aggregation is inhibited by protein-tyrosine kinase inhibitors, ST638 and genistein.
    Asahi M; Yanagi S; Ohta S; Inazu T; Sakai K; Takeuchi F; Taniguchi T; Yamamura H
    FEBS Lett; 1992 Aug; 309(1):10-4. PubMed ID: 1511739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troglitazone and pioglitazone attenuate agonist-dependent Ca2+ mobilization and cell proliferation in vascular smooth muscle cells.
    Asano M; Nakajima T; Iwasawa K; Morita T; Nakamura F; Imuta H; Chisaki K; Yamada N; Omata M; Okuda Y
    Br J Pharmacol; 1999 Oct; 128(3):673-83. PubMed ID: 10516648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.